Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aimee Caires"'
Autor:
Judith Stamberg, Chen Chih Sun, Jeffrey A. Toretsky, Allen E. Eskenazi, Andrew B. Campbell, Stephen P. Hunger, Christopher N. Frantz, James Jenson, J. Laurance Hill, Aimee Caires
Publikováno v:
American Journal of Clinical Oncology. 26:300-306
Thymic carcinoma is a rare epithelial neoplasm of the thymus. The presence of a specific chromosomal abnormality may augment diagnosis and therapeutic stratification. We report a 15-year-old boy diagnosed with thymic carcinoma who presented with a la
Autor:
Theresa Boomer, Marileila Varella-Garcia, M Imaizumi, Victor Prima, Stephen P. Hunger, Aimee Caires, Lia Gore, Miyako Yoshinari
Publikováno v:
Leukemia. 19(5)
We analyzed the TS-2 acute lymphoblastic leukemia (ALL) cell line that contains a t(1;19)(q23;p13.3) but lacks E2A-PBX1 fusion typically present in leukemias with this translocation. We found that the t(1;19) in TS-2 fuses the 19p13 gene DAZAP1 (Dele
Autor:
Adrie van Bokhoven, Gary J. Miller, M. Scott Lucia, Steven K. Nordeen, Aline P. Schulte, Michael V. Di Maria, Aimee Caires, Marileila Varella-Garcia
Publikováno v:
The Prostate. 57(3)
BACKGROUND. Well-characterized in vitro model systems provide an invaluable tool for studying prostate cancer in the laboratory. Detailed karyotypes have been reported using modern techniques such as multiplex fluorescence in situ hybridization (M-FI
Autor:
Theresa Boomer, Stephen P. Hunger, Varella-Garcia Marileila, Victor Prima, Aimee Caires, Imaizume Masue, Lia Gore, Miyako Yoshinari
Publikováno v:
Blood. 104:548-548
The t(1;19)(q23;p13) is one of the most common chromosome translocations in ALL. In 90–95% of ALL cases with a t(1;19), the 19p13.3 gene E2A is fused to PBX1 located at 1q23, producing E2A-PBX1 chimeric proteins that possess transforming properties
Autor:
Jeffrey A. Toretsky, James Jenson, Chen-Chih Sun, Allen E. Eskenazi, Andrew Campbell, Stephen P. Hunger, Aimee Caires, Christopher Frantz, J. Laurance Hill, Judith Stamberg
Publikováno v:
American Journal of Clinical Oncology; Jun2003, Vol. 26 Issue 3, p300-306, 7p